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anatomic regions and within any given
tissue.
Steinert et al. also interrogate the
second assumption: that TRM faithfully
express CD69 and/or CD103 and are not
accessible to intravascular antibody. Us-
ing parabiotic pairs of congenic mice,
which were surgically joined to establish
a shared blood circulation, the authors
discover that a sizeable fraction of TRM
express neither CD69 nor CD103, and
some TRM, especially in the kidney and
liver, actually appear to reside within the
intravascular space.
These findings have implications for
how immunologists think about T cell
surveillance of tissues, particularly with
regard to TRM. For example, in the FRT,
isolation-based methods had estimated
that there is one TRM for every 20,000
nucleated cells, while tissue microscopy
performed by Steinert et al. reveals that
there is one TRM for every300 nucleated
cells. Assuming that TRM within the FRT
scan cells at a similar rate to those in the
skin (Ariotti et al., 2012), isolation-based
methods project that TRM would require704 Cell 161, May 7, 2015 ª2015 Elsevier Inc1 month to scan every cell in the FRT.
In contrast, the tissue microscopy data
imply that TRM scan the FRT in its entirety
within 12 hr, an estimate that is much
more consistent with the reported effec-
tiveness of TRM to protect non-lymphoid
tissues (Mackay et al., 2012).
Steinert and colleagues thus provide a
much-needed reality check for immunolo-
gists. Their findings will have to be taken
into account when evaluating immune
responses to vaccines and pathogens,
and it will be important to determine their
impact on our understanding of allergic
and autoimmune diseases, as well as im-
muno-oncology.
Even though 80 years have passed
since the Literary Digest fiasco, this study
provides a stern reminder that sample
bias is not a fiction of the past but remains
to this day a fact to be reckoned with—by
scientists and voters alike.REFERENCES
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Cancer is known for opportunistically utilizing resources from its surroundings for its own growth
and survival. In this issue of Cell, Venkatesh et al. demonstrate that this also occurs in the brain,
identifying neuronal activity-induced secretion of neuroligin-3 as a novel mechanism promoting
glioma proliferation.Cancer is notorious for hijacking normal
biological processes to promote tumor
cell survival, migration, and proliferation.
Cancer cells release angiogenic factors
that promote blood vessel formation to
support their own survival and upregulate
molecules normally expressed by healthy
cells to evade immune detection. In their
recent study, Venkatesh et al. (2015)
reveal that cancer cells also take advan-
tage of neuronal activity, the most essen-tial aspect of brain function, in order to
proliferate. The authors demonstrate that
optogenetic stimulation of neurons can
promote the growth of human high-grade
gliomas (HGGs) by inducing the secretion
of mitogenic factors.
This study was initiated following the
discovery that neuronal activity stimulates
the proliferation of oligodendrocyte pre-
cursor cells (OPCs) and neuronal precur-
sor cells (NPCs) in vivo (Gibson et al.,2014), cells that can give rise to gliomas
(Cuddapah et al., 2014). Both studies uti-
lized optogenetic strategies to increase
neuronal activity by stimulating channelr-
hodopsin-expressing neurons with blue
light (Figure 1A). This approach enables
the activation of subsets of neurons in
defined circuits in a physiological manner
and allows for comparisons between
different circuits or regions from within
the same brain. Importantly, this method
Figure 1. Optogenetic Techniques Reveal
that Activity-Induced Secretion of Neuro-
ligin-3 Promotes Glioma Growth
(A) In vivo optogenetic stimulation of Thy1::ChR2
premotor cortex promotes the proliferation of
xenografted glioblastoma cells.
(B) In vitro optogenetic stimulation of Thy1::ChR2
cortical slices leads to activity-regulated secretion
of factors into the media.
(C) Conditioned medium from stimulated cortical
slices induces growth of patient-derived glioma
cells in vitro. Venkatesh et al. identify secreted
neuroligin-3 as their primary candidate mitogen
and propose a downstream signaling pathway
involving PI3K and mTOR.can be used to stimulate the brains of
awake, behaving animals.
Venkateshet al. put this technique touse
in their orthotopic xenograftmodel of pedi-
atric HGG. To create this model, the au-
thors xenografted cells cultured from a bi-
opsy of frontal cortex glioblastoma from a
15-year-old patient into the premotor cor-
tex of immunodeficient mice that had
been crossed to the Thy1::ChR2 line,
which would allow for activation of neural
tissue surrounding the xenografted cells.
Just as in non-pathological experimentswith OPCs and NPCs, optogenetic stimu-
lation of neuronal activity using blue light
induced proliferation of xenografted
pediatric HGG cells. A single stimulation
was sufficient to induce proliferation;
however, repetitive stimulation over the
course of a week further increased tumor
cell burden.
The authors next moved to an in vitro
system to investigate the mechanism
underlying neuronal activity-induced
glioma proliferation (Figure 1B). After
determining that conditioned medium
collected from optogenetically stimulated
Thy1::ChR2 cortical slices could induce
the proliferation of a variety of different
patient-derived HGG cell cultures
(Figure 1C), Venkatesh et al. sought to
identify the secreted signal responsible.
Glioma cells express ion channels and
neurotransmitter receptors and are sensi-
tive to calcium, and, therefore, could
proliferate in response to a variety of
secreted signals (Cuddapah et al.,
2014). Using mass spectrometry, the au-
thors identified secreted neuroligin-3 in
the cortical slice-conditioned medium as
their primary candidate mitogen and
confirmed its ability to induce the prolifer-
ation of multiple types of HGG using a
recombinant protein. Importantly, the
neuroligin-3 found in the conditioned me-
dium contained only the ectodomain,
suggesting that it is cleaved in a similar
manner to known family member neuroli-
gin-1 (Peixoto et al., 2012; Suzuki et al.,
2012).
To understand how neuroligin-3 could
exert this mitogenic effect, the authors
performed RNA sequencing followed by
western blot analysis on cultured glioma
cells that had been treated with either
light-exposed WT or Thy1::ChR2-condi-
tioned medium. They determined that
neuronal activity-regulated secretion of
neuroligin-3 promoted glioma cell prolif-
eration through activation of the PI3K-
mTOR pathway (Figure 1C). Interestingly,
this pathway activated both transcription
and translation of neuroligin-3 in glioma
cells, suggesting a feedforward signaling
loop. Increased neuroligin-3 expression
by tumor cells may indeed be pathogenic,
as the authors found an inverse rela-
tionship between adult glioblastoma
neuroligin-3 mRNA expression and pa-
tient survival upon analyzing data from
The Cancer Genome Atlas. On average,Celpatients categorized as having high levels
of glioblastoma neuroligin-3 expression
had a lifespan that was 5 months shorter
than that of patients with low expression
of neuroligin-3. This effect was specific,
as there was no association between
expression of neuroligin-2, which does
not induce glioma cell proliferation
in vitro, and patient survival.
The finding that neuronal activity pro-
motes glioma proliferation raises a num-
ber of interesting questions. Previous
studies have found that cancer cells
secrete glutamate, which may stimulate
their own proliferation, and that glutamate
secretion may also be linked to the epi-
lepsy developed by many glioma patients
(Buckingham et al., 2011). Given this
new link between neuronal activity and
glioma growth, one question that arises
is whether tumor-associated epilepsy
serves as another type of feedforward
mechanism to support further glioma pro-
liferation. Additionally, this link may also
shed light on studies that demonstrate
an increased likelihood of brain tumor
development in patients who have been
treated for epilepsy, which is not very
well understood (Khan et al., 2011).
The discovery of neuroligin-3 as a po-
tential mitogen is also unexpected, given
its role as a postsynaptic adhesion mole-
cule required for normal synaptic function
and its implication as a disease gene in
autism (Su¨dhof, 2008). This study sug-
gests that neuroligin-3 may play other
roles in non-neuronal cells and that
secreted neuroligin-3 may regulate its
own transcription. Additional work is
necessary to understand the mechanism
outlined in this study, including the cellular
origin of secreted neuroligin-3, the
activity-dependent neurolign-3 cleavage
mechanism, the recruitment of down-
stream PI3K, and the function of tumor-
derived neuroligin-3. Some insight into
neuroligin-3 cleavage may be gleaned
from studies that have examined neuroli-
gin-1, which has been shown to exhibit
activity-dependent cleavage and secre-
tion of its ectodomain (Peixoto et al.,
2012; Suzuki et al., 2012). These findings
also highlight the need to investigate the
role of secreted neuroligin-3 in the healthy
brain and whether the feedforward
pathway is utilized for growth of healthy
OPCs and NPCs or only arises in glioma
cells.l 161, May 7, 2015 ª2015 Elsevier Inc. 705
Venkatesh et al. provide invaluable
insight into HGG, revealing not only a
greater mechanistic understanding of
the regulation of glioma growth, but
also a potential therapeutic target in
neuroligin-3. Their observations that
neuronal activity promotes the prolifera-
tion of multiple glioma types and that
neuroligin-3 is mutated in a variety of
different types of cancers, combined
with recent studies implicating auto-
nomic innervation with cancer progres-
sion in other systems (Magnon et al.,
2013; Zhao et al., 2014), suggest that
this mechanism may be broadly appli-
cable to many cancers.706 Cell 161, May 7, 2015 ª2015 Elsevier IncREFERENCES
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Cone photoreceptors, responsible for high-resolution and color vision, progressively degenerate
following the death of rod photoreceptors in the blinding disease retinitis pigmentosa. Aı¨t-Ali
et al. describe a molecular mechanism by which RdCVF, a factor normally released by rods, con-
trols glucose entry into cones, enhancing their survival.The retina is a highly sophisticated biolog-
ical computer that captures an image with
its photoreceptors and extracts different
visual features to describe the visual
scene to higher brain centers in simple
and compact terms. Although photore-
ceptors, the rods and cones, are only
two out of the sixty retinal cell types,
they are exceptionally important: all
image-forming vision depends on their
proper function. Despite the fact that
rods outnumber cones 20 to 1, human
vision is mostly based on cones. Rods
are distributed at the periphery of the
retina and are the photosensors for low
light levels. Cones are concentrated in
the center of the retina and work at higher
light levels. Since cones are necessary for
the high-resolution color vision that en-
ables us to read, recognize faces, and en-
joy the colorful world, in the modern worldwe surround ourselves with enough light
to turn on the cones. Most of us spend lit-
tle time in conditions where photons are
scarce and, therefore, our dependence
on rod function is minor. A study pre-
sented in this issue of Cell offers key
insight into the interdependence of rods
and cones, and how it is disrupted in the
genetic disorder retinitis pigmentosa
(Aı¨t-Ali et al., 2015)
The genes involved in retinitis pigmen-
tosa are primarily expressed only in rods
and are important for their function (Har-
tong et al., 2006). If humans rely mostly
on cone vision, why is this disease so se-
vere? The reason stems from the fact that
rods and cones are dependent on each
other. When rods are dysfunctional but
alive, as in another genetic disease called
stationary night blindness, cones are
functional. Indeed, patients with station-ary night blindness are capable of living
an almost normal life. However, when
rods die, as happens in retinitis pigmen-
tosa, cones sense this loss and react to
it. This reaction is devastating. First,
cones lose their outer segments, which
serve as light detectors, causing patients
to become blind. Second, on a longer
timescale, the other parts of the cones
progressively degenerate.
Due to the importance of cones for hu-
man vision, and their dependence on
rods, two fundamental questions in reti-
nitis pigmentosa research are why and
how do cones react to rod death and
how can we prevent cones from degen-
erating?. There have been several im-
portant insights in recent years. One of
these insights, originating in Jose´-Alain
Sahelʼs laboratory, came from the logic
that if rods are necessary for cone
